Patrick John Flynn serves as Executive at NRX Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Patrick John Flynn has executed 8 insider transactions totaling $14.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 28, 2022 involved purchasing 2,500 shares valued at $3.1K.
Patrick John Flynn currently holds 37,709 shares of NRX Pharmaceuticals, Inc. (NRXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patrick John Flynn has been a net buyer of NRXP stock. They have purchased $14.7K and sold $0 worth of shares.
Patrick John Flynn's most recent insider trade was on Nov 28, 2022, when they purchased 2,500 shares at $1.25 per share.
Get notified when new Form 4 filings are submitted
| $1.25 |
| Discretionary |
| Nov 28, 2022 | NRXP | $3.1K | Purchase | 2,500 | $1.24 | Discretionary |
| Nov 28, 2022 | NRXP | $2.2K | Purchase | 1,750 | $1.25 | Discretionary |
| Nov 28, 2022 | NRXP | $3.1K | Purchase | 2,500 | $1.25 | Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 362,332 | $N/A | Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 35,209 | $N/A | Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 35,209 | $N/A | Discretionary |